Generali Investments Management Co LLC Raises Stock Position in Merck & Co., Inc. $MRK

Generali Investments Management Co LLC increased its stake in Merck & Co., Inc. (MRK) by 32.2% in the fourth quarter of 2025, bringing its total holdings to 49,160 shares valued at $5.175 million. Merck reported strong Q4 earnings, beating analyst estimates, and provided positive FY2026 guidance, alongside a stable dividend. Despite insider selling and some challenges in specific vaccine markets, the company benefits from strategic partnerships, such as with Google Cloud for AI in drug discovery, and FDA Priority Review for its KEYTRUDA regimen.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin